Eisai Completes New Oral Solid-Dose Plant in China

Eisai’s Chinese subsidiary has completed a new oral solid dose (OSD) production facility and an administration building in China at the site of its new Suzhou plant located within the Suzhou Industrial Park.The facility—whose value was not disclosed—occupies a new industrial site more than five times the size of its current Suzhou plant (OSD production facility), which opened in November 2014 and oversees the subsidiary’s manufacturing of the injection formulation of the